Notice and Comment – Regulatory Burden Reduction
The Board proposed changes to its CPI-Adjustment Methodology and to the Patented Medicines Regulations through its Notice and Comment published on May 16, 2013.
The Board received 12 submissions in response to its Notice and Comment on the proposed changes. And Board Staff is currently studying the feedback. An update on next steps will be available in the July 2013 NEWSletter. The Board wishes to thank stakeholders for their participation.
Further information on the role and process of the Board may also be obtained from the Director, Board Secretariat, by calling the PMPRB's toll-free line: 1-877-860-2150 or 613-954-8299.